1. CANADIAN CANCER TRIALS GROUP (CCTG) LY.17: A RANDOMIZED PHASE II STUDY EVALUATING NOVEL SALVAGE THERAPY PRE‐AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RR‐DLBCL) ‐ OUTCOME OF IBRUTINIB + R‐GDP. (June 2017) Authors: Kuruvilla, J.; Crump, M.; Villa, D.; Aslam, M.; Prica, A.; Scott, D.W.; Abdel‐Samad, N.; Couban, S.; Doucet, S.; Dudebout, J.; Fleury, I.; Fraser, G.; Larouche, J.; Shafey, M.; Skrabek, P.; Skamene, T.; Winch, C.; Shepherd, L.; Chen, B.E.; Hay, A.E. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗